Cargando…

Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders

Aging is characterized by the functional decline of the immune system and constitutes the primary risk factor for infectious diseases, cardiovascular disorders, cancer, and neurodegenerative disorders. Blood vessels are immune-privileged sites and consist of endothelial cells, vascular smooth muscle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Ryu, Hashimoto, Motomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039280/ https://www.ncbi.nlm.nih.gov/pubmed/35493934 http://dx.doi.org/10.3389/fnagi.2022.843305

Ejemplares similares

Giant cell arteritis: immune and vascular aging as disease risk factors
por: Mohan, Shalini V, et al.
Publicado: (2011)

New Insights into the Pathogenesis of Giant Cell Arteritis: Mechanisms Involved in Maintaining Vascular Inflammation
por: Greigert, Hélène, et al.
Publicado: (2022)

Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis
por: Esen, Idil, et al.
Publicado: (2021)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis
por: van Sleen, Yannick, et al.
Publicado: (2019)

A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis
por: Kadoba, Keiichiro, et al.
Publicado: (2021)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis
por: Seitz, Luca, et al.
Publicado: (2021)

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply
por: Esen, Idil, et al.
Publicado: (2022)

Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes
Publicado: (1994)

Cardiovascular Magnetic Resonance Detects Myocardial Inflammation in Giant Cell Arteritis
por: Mavrogeni, Sophie I., et al.
Publicado: (2021)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling
por: Ly, Kim Heang, et al.
Publicado: (2014)

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
por: Goodfellow, Nicola, et al.
Publicado: (2017)

ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies
por: Wang, Lihui, et al.
Publicado: (2020)

Pharmacotherapeutic potential of pomegranate in age-related neurological disorders
por: Emami Kazemabad, Mohammad Javad, et al.
Publicado: (2022)

Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis
por: Yoshida, Shuhei, et al.
Publicado: (2023)

Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)

Treatment of Giant Cell Arteritis (GCA)
por: Régent, Alexis, et al.
Publicado: (2022)

An Unusual Case of Giant Cell Arteritis
por: Goyal, Nitasha, et al.
Publicado: (2022)

Evolution of ultrasound in giant cell arteritis
por: Kirby, Colm, et al.
Publicado: (2022)

Cardiovascular lesions in giant cell arteritis
por: Dzhus, Marta, et al.
Publicado: (2022)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Clinical Experience With a Multidisciplinary Model of Vascular Ultrasound for the Evaluation for Giant Cell Arteritis
por: Tedeschi, Sara K., et al.
Publicado: (2021)

Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?
por: Mortensen, Peter W., et al.
Publicado: (2022)

Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis
por: Johnson, Victoria L, et al.
Publicado: (2021)

Mönckeberg sclerosis with giant cells as a masquerade of giant cell arteritis
por: Johannemann, Andrew, et al.
Publicado: (2021)

Vertebrobasilar Infarction Related to Giant Cell (Temporal) Arteritis: Case Report
por: HAISA, Toshihiko, et al.
Publicado: (2015)

Mimickers of Large Vessel Giant Cell Arteritis
por: Ramon, André, et al.
Publicado: (2022)

Ocular Syphilis Mimicking Giant Cell Arteritis
por: Qadir, Areebah, et al.
Publicado: (2022)

Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)

Giant Cell Arteritis Presenting as Choroidal Infarction
por: Kopsachilis, Nikolaos, et al.
Publicado: (2013)

Abdominal aortic aneurysm in giant cell arteritis
por: Kwon, Hyunwook, et al.
Publicado: (2015)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0qpj4tcfaqv4p7dorl65la5upp